Cargando…
The investigation of a traditional Chinese medicine, Guizhi Fuling Wan (GFW) as an intravesical therapeutic agent for urothelial carcinoma of the bladder
BACKGROUND: The high risk of recurrence faced by patients with bladder cancer has necessitated the administration of supplemental intravesical chemotherapy; however, such treatments often result in severe side effects. As a result, novel intravesical agents with enhanced efficacy and minimal toxicit...
Autores principales: | Lu, Chi-Chen, Lin, Mei-Yi, Chen, Syue-Yi, Shen, Cheng-Huang, Chen, Lih-Geeng, Hsieh, Hsiao-Yen, Chan, Michael WY, Hsu, Cheng-Da |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3599278/ https://www.ncbi.nlm.nih.gov/pubmed/23433042 http://dx.doi.org/10.1186/1472-6882-13-44 |
Ejemplares similares
-
Efficacy of Guizhi Fuling Wan for primary dysmenorrhea: protocol for a randomized controlled trial
por: Du, Yun, et al.
Publicado: (2021) -
A network pharmacology approach to investigate the pharmacological effects of Guizhi Fuling Wan on uterine fibroids
por: Zeng, Liuting, et al.
Publicado: (2017) -
Integrating Network Pharmacology and Experimental Validation Deciphers the Mechanism of Guizhi Fuling Wan against Adenomyosis
por: Wang, Haoxian, et al.
Publicado: (2021) -
Correction to: Efficacy of Guizhi Fuling Wan for primary dysmenorrhea: protocol for a randomized controlled trial
por: Du, Yun, et al.
Publicado: (2021) -
Guizhi Fuling wan for chronic pelvic inflammatory disease protocol: A protocol for systematic review and meta analysis
por: Wang, Chunrong, et al.
Publicado: (2020)